Tocilizumab in rheumatoid arthritis: efficacy, safety and its place in therapy

被引：42

作者：

Kaneko, Atsushi ^{[1
]}

机构：

[1] Natl Hosp Org Japan, Nagoya Med Ctr, Dept Orthopaed Surg & Rheumatol, Naka Ku, 4-1-1 Sannomaru, Nagoya, Aichi 4600001, Japan

来源：

THERAPEUTIC ADVANCES IN CHRONIC DISEASE | 2013年 / 4卷 / 01期

关键词：

biological disease-modifying antirheumatic drug; interleukin-6; rheumatoid arthritis; tocilizumab;

D O I：

10.1177/2040622312466908

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

Tocilizumab is a humanized antihuman interleukin-6 (IL-6) receptor monoclonal antibody. It was developed in Japan as the first biological disease-modifying antirheumatic drug targeting IL-6 receptors. Many large-scale global studies have demonstrated its efficacy and safety, and in April 2008 it was approved in Japan for use in the treatment of rheumatoid arthritis, sooner than in other countries. In this paper, I review the efficacy and safety of tocilizumab in the light of front-line clinical data and data from large-scale studies, and I consider the place of tocilizumab treatment in real clinical practice.

引用

页码：15 / 21

页数：7

共 50 条

[1] Tocilizumab: A Review of Its Safety and Efficacy in Rheumatoid Arthritis
Jones, Graeme
Ding, Changhai
[J]. CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2010, 3 : 81 - 89
[2] Safety and Efficacy of Tocilizumab for the Treatment of Rheumatoid Arthritis
Ogata, Atsushi
Hirano, Toru
Hishitani, Yoshihiro
Tanaka, Toshio
[J]. CLINICAL MEDICINE INSIGHTS-ARTHRITIS AND MUSCULOSKELETAL DISORDERS, 2012, 5 : 27 - 42
[3] Efficacy and safety of tocilizumab in elderly patients with rheumatoid arthritis
Pers, Yves-Marie
Schaub, Roxane
Constant, Elodie
Lambert, Joseph
Godfrin-Valnet, Marie
Fortunet, Clementine
Bourichi, Waafa
Prades, Beatrice Pallot
Wendling, Daniel
Gaudin, Philippe
Jorgensen, Christian
Maillefert, Jean-Francis
Marotte, Hubert
[J]. JOINT BONE SPINE, 2015, 82 (01) : 25 - 30
[4] EFFICACY AND SAFETY OF TOCILIZUMAB IN ELDERLY PATIENTS WITH RHEUMATOID ARTHRITIS
Pers, Y. -M.
Schaub, R.
Fortunet, C.
Constant, E.
Lambert, J.
Godfrin-Valnet, M.
Pallot-Prades, B.
Wendling, D.
Gaudin, P.
Marotte, H.
Maillefert, J. -F.
Jorgensen, C.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 689 - 689
[5] EFFICACY AND SAFETY OF TOCILIZUMAB THERAPY IN RHEUMATOID ARTHRITIS: PREVALENCE AND PREDICTIVE FACTORS OF SUSTAINED REMISSION
Tanaka, H.
Kanazawa, M.
Kawakami, T.
Kido, K.
Kifune, M.
Kubo, M.
Tamimoto, Y.
Tokitou, T.
Tokushige, A.
Nibu, K.
Miyazaki, N.
Mitasato, H.
Yamamoto, K.
Yamamoto, M.
Watada, T.
Fukuta, S.
Taguchi, T.
[J]. ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 453 - 453
[6] Efficacy and safety of tocilizumab in Korean patients with active rheumatoid arthritis
Baek, Han Joo
Lim, Mie Jin
Park, Won
Park, Sung Hwan
Shim, Seung-Cheol
Yoo, Dae-Hyun
Kim, Hyun Ah
Lee, Soo Kon
Lee, Yun Jong
Park, Young Eun
Cha, Hoon-Suk
Song, Yeong-Wook
[J]. KOREAN JOURNAL OF INTERNAL MEDICINE, 2019, 34 (04): : 917 - 931
[7] A Study of the Efficacy and Safety of Subcutaneous Injections of Tocilizumab in Adults with Rheumatoid Arthritis
Langevitz, Pnina
Lidar, Merav
Rosner, Itzhak
Feld, Joy
Tishler, Moshe
Amital, Howard
Aamar, Suhail
Elkayam, Ori
Balbir-Gurman, Alexandra
Abu-Shakra, Mahmoud
Mevorach, Dror
Kimhi, Oded
Molad, Yair
Kuperman, Ana
Ehrlich, Sharon
[J]. ISRAEL MEDICAL ASSOCIATION JOURNAL, 2020, 22 (09): : 491 - 497
[8] Clinical safety of tocilizumab in rheumatoid arthritis
Bannwarth, Bernard
Richez, Christophe
[J]. EXPERT OPINION ON DRUG SAFETY, 2011, 10 (01) : 123 - 131
[9] THE CLINICAL EFFICACY OF TOCILIZUMAB IN RHEUMATOID ARTHRITIS
Mircic, Maja
Kavanaugh, Arthur
[J]. DRUGS OF TODAY, 2009, 45 (03) : 189 - 197
[10] Safety and efficacy Tocilizumab therapy in children with juvenile idiopathic arthritis
Alexeeva, Ekaterina
Denisova, Rina
Bzarova, Tatyana
Valiyeva, Saniya
Isayeva, Kseniya
Lisitsyn, Alexander
Tatyana, Sleptsova
[J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 386 - 386

← 1 2 3 4 5 →